Standards & Regulation

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

The UK’s medicines regulator releases new guidance for Brexit.

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.

How is the Indian pharmaceutical industry adapting to meet new demands?

Drug development needs to move more rapidly, but not at the expense of safety.

We’re making progress on standardizing single-use systems – and it could mean a more cost-effective supply chain.

How are counterfeiters exploiting the COVID-19 pandemic to make a profit?

The FDA has approved its first biosimilar of 2020: Pfizer’s Nyvepria (pegfilgrastim-apgf).

How Raman spectroscopy-based technologies enable the pharma industry to streamline analytical workflows.